A magnificent St Mark's Basilica Cathedral Church (left) and a spectacular Teatro La Fenice theatre (right) have completed our memorizable trip in Venice, Italy. 09.06.23

I will be giving a presentation tomorrow at #BIC2023 on pathogenesis of thrombotic thrombocytopenic purpura (TTP): the mechanism of antibody-mediated inhibition of ADAMTS13 in this amazing historic theatre (Teatro Biondo Palermo)

It has been an honor and privilege to have the opportunity to speak at such a prestigious and exciting #BIC2023 conference. Thank you for your interest.

KU Medical Center has nearly doubled its federal research portfolio since 2017 and increased its clinical trial revenues by 45% since 2021. "I continue to be amazed at the success of our research community." - @KUEVC_Simari. bit.ly/3EVnIaK

Congratulations to Long Zheng , MD, PhD and his team for their recent publication “Coagulation factor VIII regulates von Willebrand factor homeostasis in vivo” in Journal of Thrombosis and Haemostasis. sciencedirect.com/science/articl…

Happy Saturday ! It was almost impossible to see the road at 7:00 am driving eastward……with the sun right in front of your car.

Chang Liu, MD, PhD, an associate professor of Pathology and Immunology from Washington University in St. Louis gave a fantastic talk to KU Pathology residents on HLA testing in precision medicine of transplantation. 11-03-2023.

Beautiful autumn colors in the residential area in Mission Hills, Kansas.

Hot off press from my group KU Medical Center about the role of assessing plasma von Willebrand factor and #ADAMTS13 in predicting mortality in patients with #COVID19, suggesting a potential novel therapeutic strategy. mdpi.com/2566466 #mdpijcm via JCM MDPI

New publication in The Company of Biologists from Khursheed Iqbal, Michael Soares, Geetu Tuteja, Jay Vivian, Regan Scott, @havu0201, and collaborators: "Conditionally mutant animal model for investigating the invasive trophoblast cell lineage" journals.biologists.com/dev/article/do…

Dr. Noritaka Yada in my Laboratory at #KUPathology reported how ADAMTS13 or Caplacizumab Reduces the Accumulation of Neutrophil Extracellular Traps and Thrombus in Whole Blood of COVID-19 patients Under Flow. pubmed.ncbi.nlm.nih.gov/38272066/

Based on literature and new information obtained in my laboratory KU Pathology & Laboratory Medicine, I propose a new model explaining how #autoantibodies may result in severe deficiency of plasma #ADAMTS13 activity in immune #thrombotic #thrombocytopenia (iTTP). jthjournal.org/article/S1538-….

I am humbled and honored to receive this prestigious award from Chinese American Pathologists Association (CAPA).

Congrats to all faculty KU Pathology & Laboratory Medicine for their success of 18.3-million-dollar NIH awards in 2023, ranked #15 among all universities (both private and public) & #6 among public universities. Thank you for your hard work & invaluable contributions to the success of the department!

Dr. Jim Pru from University of Wyoming gave an excellent seminar at a pathology grand round on pleiotropic action of PGRMC proteins in fertility and disease. Thank you.

I am pleased to have the opportunity to visit and give a seminar at Florida State for undergraduate and graduate students at the department of chemical and biomedical engineering. I learned a lot about blood coagulation from engineering prospects.

Thank you Dr. Donald Siegel, MD, PhD, for a fantastic #Lecture: 'Innovations in Novel Cellular Therapies for Cancer, Autoimmune Disease and Other Maladies' #Research

Welcome to KU Pathology & Laboratory Medicine and laboratory medicine, Dr. Liz Manion!

Welcome to the department, Melody.

A mutant complement factor H (W1183R) enhances proteolytic cleavage of von Willebrand factor by ADAMTS-13 under shear - Journal of Thrombosis and Haemostasis jthjournal.org/article/S1538-…